Steven W. Spector is CLO & VP +1 at ARENA PHARMACEUTICALS INC (ARNA). They have made 5 open-market trades across 1 company since 2007, most recently 2020-02-27.
CIK 0001170362
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ARNA | 17,437 | $1.7M |
Shares reported on the most recent Form 4, priced at the 2020-02-28 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ARNA | SELL | 2020-02-13 | 2020-02-14 | $55.00 | $596K | -18.2% | -32.6% | -16.0% |
| ARNA | SELL | 2019-09-09 | 2019-09-10 | $50.63 | $3.4M | -2.0% | -10.8% | -6.1% |
| ARNA | SELL | 2019-02-01 | 2019-02-04 | $46.10 | $69K | +0.5% | -4.2% | +2.9% |
| ARNA | SELL | 2018-08-15 | 2018-08-17 | $36.01 | $2.1M | +6.4% | +16.4% | +10.7% |
| ARNA | SELL | 2018-04-16 | 2018-04-18 | $34.47 | $1.8M | +1.2% | +15.7% | +13.3% |
| ARNA | SELL · 10b5-1 | 2015-03-17 | 2015-03-18 | $5.00 | $350K | -15.2% | -4.2% | -4.2% |
| ARNA | SELL · 10b5-1 | 2015-01-08 | 2015-01-08 | $6.26 | $282K | -15.2% | -4.2% | -4.2% |
| ARNA | SELL · 10b5-1 | 2014-05-12 | 2014-05-14 | $7.05 | $317K | -15.2% | -4.2% | -4.2% |
| ARNA | SELL · 10b5-1 | 2014-03-04 | 2014-03-05 | $7.01 | $175K | -15.2% | -4.2% | -4.2% |
| ARNA | SELL · 10b5-1 | 2014-01-09 | 2014-01-13 | $6.10 | $203K | -15.2% | -4.2% | -4.2% |
| ARNA | SELL · 10b5-1 | 2013-11-12 | 2013-11-13 | $5.19 | $104K | -15.2% | -4.2% | -4.2% |
| ARNA | SELL · 10b5-1 | 2013-09-05 | 2013-09-06 | $6.54 | $131K | -15.2% | -4.2% | -4.2% |
| ARNA | SELL · 10b5-1 | 2012-07-02 | 2012-07-03 | $9.99 | $1.6M | -15.2% | -4.2% | -4.2% |
| ARNA | SELL · 10b5-1 | 2007-10-01 | 2007-10-02 | $11.00 | $110K | -15.2% | -4.2% | -4.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.